Disclosures: Patrick INGILIZ: GILEAD: Speaking and Teaching, Abbvie: Speaking and Teaching, ViiV: Speaking and Teaching, Erwan Vo Quang: Nothing to Disclose, Maud Lemoine: Nothing to Disclose, Amie Ceesay: Nothing to Disclose, Gibril Ndow: Nothing to Disclose, Marie-Noelle Hilleret: Nothing to Disclose, Laure Bordy: Nothing to Disclose, Thomas Decaens: Nothing to Disclose, Anne-Laure Mazialivoua: Nothing to Disclose, Yusuke Shimakava: Nothing to Disclose, Alhagie Bakoteh: Nothing to Disclose, Jean-Michel Pawlotsky: Abbvie: Speaker, Abbott: Advisor, Gilead: Speaking and Teaching, GSK: Advisor, Isabelle CHEMIN: Nothing to Disclose, Stphane Chevaliez: Nothing to Disclose, Vincent Leroy: Nothing to Disclose 448 HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION Emin Bodakci 1 Saba Kiremiti 1 Serkan Duman 1 Zeynep Melekoglu Ellik 1 Mesut Gumussoy 1 Sevinc Tue Guvenir 1 Volkan YILMAZ 1 ramazan erdem er 1 Fatih Karakaya 1 Hale Gokcan 1 Atilla Elhan 1 Berna Savas 1 Ramazan Idilman 1 , 1 Ankara University Background: The present study aimed to determine the effect of hepatic steatosis detected by liver biopsy on HBsAg seroclearance and disease outcome in hepatitis B virus (HBV)-infected patients
Rocio Salas-Whalen, a physician specializing in endocrinology, obesity, and metabolic health, and the author of Weightless: A Doctor's Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve
Assessing the risk for gout with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a population-based cohort study
So less fat, more of your testosterone in men stays as testosterone and wont convert to estrogen. Over time, some men may even be able to wean off TRT under medical supervision, says Kohn
Finding your ideal range is unique to each individual, but, more importantly, it requires oversight and approval from your physician
